FDA Finalizes REMS Guidance

Article

The FDA guidance defines changes to approved risk evaluation and mitigation strategies and clarifies submission guidelines.

FDA published the final version of its REMS guidance document, Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry, on July 9, 2019. The guidance provides information on types of approved risk evaluation and mitigation strategies (REMS) and how applicants should submit changes to an approved REMS. The guidance also clarifies the differences between modifications of a REMS and revisions of a REMS.

FDA timeframes for assessing REMS changes-including revisions, minor modifications, major modifications, modifications due to safety labeling changes, and multiple types of REMS changes-are also included in the document. An appendix provides detailed submission procedures.

The guidance applies to all types of REMS but does not address additional submission procedures that may apply to application holders proposing changes to a shared system and that use a drug master file for their REMS submission.

Source: FDA

 

Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content
© 2025 MJH Life Sciences

All rights reserved.